Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T…
REDWOOD CITY, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative…
Phase I/II trial assessing the safety and efficacy of RECCE® 327 (R327), a broad-spectrum anti-infective as a topical treatment, met…
NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in 28-patient clinical trialProgram developed…
DENVER, Jan. 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in…
STOCKHOLM, SE / ACCESSWIRE / January 23, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) During today's initial trading, the price of…
DENVER--(BUSINESS WIRE)--#WestFax--WestFax proudly unveils its latest advancement in healthcare secure cloud fax technology: the CloudFax Toolkit (CFT). This toolkit is…
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and…
Mississauga, Ontario--(Newsfile Corp. - January 22, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a medical technology company,…
CHICAGO, IL / ACCESSWIRE / January 22, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT), the Association…